 | Up a level |
Zeitlberger, A M; Putora, P M; Hofer, S; Schucht, P; Migliorini, D; Hottinger, A F; Roelcke, U; Läubli, H; Spina, P; Bozinov, O; Weller, M; Neidert, M C; Hundsberger, T (2022). Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis. Journal of neuro-oncology, 158(3), pp. 359-367. Springer 10.1007/s11060-022-04022-7
Wirsching, H-G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, Ludwig; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J; ... (2018). Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology, 29(6), pp. 1423-1430. Oxford University Press 10.1093/annonc/mdy120
Diener, HC; Weimar, C; Berlit, P; Dueschl, G; Elger, C; Gold, R; Hacke, W; Hufschmidt, A; Mattle, H; Meier, U; Oertel, WH; Reichmann, H; Schmutzhard, E; Wallesch, C-W; Weller, M (eds.) (2012). Leitlinien für Diagnostik und Therapie in der Neurologie. 5. vollständig überarbeitete Auflage. Stuttgart: Thieme
